Advanced Registry Search Results

Search Criteria
  1. Lobbyist name (consultant or in-house lobbyist): MONTEITH, GLENN OR;
  2. Senior Officer name: MONTEITH, GLENN
Start over
Modify criteria
Refine By
Document Type Registrations Status Activity Type Subject Matter of the Lobbying Activity Ministries/Provincial Entities

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Advanced Registry Search Results

Results: 1-7 of 7
  1. Innovative Medicines Canada (Medicaments novateurs Canada)
    Activity type: Organization
    Senior Officer: Pamela Fralick
    Registration: 7 of 58 (2018-10-18 to 2019-04-18)
    Posted: 2018-10-18
    Subject matter details: 4
    Lobbying target types: 4
    Government funding: No
    Employees who lobby: 7
    Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020.
  2. Innovative Medicines Canada (Medicaments novateurs Canada)
    Activity type: Organization
    Senior Officer: Pamela Fralick
    Registration: 6 of 58 (2018-03-27 to 2018-09-27)
    Posted: 2018-03-28
    Subject matter details: 4
    Lobbying target types: 2
    Government funding: No
    Employees who lobby: 6
    Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020.
  3. Innovative Medicines Canada (Medicaments novateurs Canada)
    Activity type: Organization
    Senior Officer: Pamela Fralick
    Registration: 5 of 58 (2017-09-25 to 2018-03-25)
    Posted: 2017-09-25
    Subject matter details: 6
    Lobbying target types: 2
    Government funding: No
    Employees who lobby: 4
    Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020.
  4. Innovative Medicines Canada (Medicaments novateurs Canada)
    Activity type: Organization
    Senior Officer: Pamela Fralick
    Registration: 4 of 58 (2017-03-22 to 2017-09-18)
    Posted: 2017-03-22
    Subject matter details: 5
    Lobbying target types: 3
    Government funding: No
    Employees who lobby: 4
    Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020.
  5. Innovative Medicines Canada (Medicaments novateurs Canada)
    Activity type: Organization
    Senior Officer: Pamela Fralick
    Registration: 3 of 58 (2016-09-22 to 2017-03-21)
    Posted: 2016-09-22
    Subject matter details: 10
    Lobbying target types: 4
    Government funding: No
    Employees who lobby: 5
    Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020.
  6. Innovative Medicines Canada (Medicaments novateurs Canada)
    Activity type: Organization
    Senior Officer: Elaine Campbell
    Registration: 2 of 58 (2016-03-24 to 2016-09-20)
    Posted: 2016-04-04
    Subject matter details: 9
    Lobbying target types: 2
    Government funding: No
    Employees who lobby: 4
    Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020.
  7. Innovative Medicines Canada (Medicaments novateurs Canada)
    Activity type: Organization
    Senior Officer: Russell Williams
    Registration: 1 of 58 (2015-09-22 to 2016-03-20)
    Posted: 2015-09-22
    Subject matter details: 10
    Lobbying target types: 3
    Government funding: No
    Employees who lobby: 5
    Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020.
Date Modified: